| Statistical methods to detect and estimate etiologic heterogeneity in epidemiologic studies |
Anil Chaturvedi |
National Cancer Institute |
PLCO |
Apr 13, 2026 |
PLCO-2038 |
| Developing an All-cancer Risk Model |
Paul Pinsky |
National Institutes of Health |
PLCO |
Apr 13, 2026 |
PLCO-2040 |
| AI-Enabled Opportunistic Detection of Cardiovascular Disease Risk from Chest Radiographs in the PLCO Cohort |
Morteza Naghavi |
HeartLung Technologies |
PLCO |
Mar 30, 2026 |
PLCOI-2034 |
| Integrative Genomic, Histologic, and Spatial Profiling of ClonalHematopoiesis in Lung Cancer |
Janghee Woo |
Emory University |
PLCO |
Mar 30, 2026 |
PLCOI-2024 |
| Pilot study of circulating immune checkpoint proteins in persons with and without cancer |
Kara Michels |
Albert Einstein College of Medicine |
PLCO |
Mar 26, 2026 |
2026-9129 |
| Validation of a bladder cancer risk model with lifestyle and environmental risk factors and polygenic risk score in two prospective cohorts. (PLCO-1972 continued) |
Parichoy Pal Choudhury |
American Cancer Society |
PLCO |
Mar 16, 2026 |
PLCO-2033 |
| Utilizing serial screening data to estimate dwell time of cancers and colorectal adenomas and develop new cancer stage progression models |
Joachim Worthington |
The University of Sydney |
PLCO |
Mar 16, 2026 |
PLCO-2032 |
| Modifiable lifestyle factors and aging |
Yikyung Park |
Washington University in St. Louis |
PLCO |
Mar 16, 2026 |
PLCO-2031 |
| Longitudinal Modelling of Prostate-Specific Antigen (PSA) Trajectories and Their Association with Prostate Cancer Diagnosis in the PLCO Trial |
Ciarán Courtney O'Toole |
University of Limerick |
PLCO |
Mar 16, 2026 |
PLCO-2025 |
| The "MetaboMap" project |
Anindya Roy |
University of Maryland Baltimore County |
PLCO |
Mar 4, 2026 |
PLCO-2030 |
| Continuation of Novel Dietary Index for Gut Microbiota and Associations with Colorectal Cancer and Breast Cancer Risk PLCO-730 |
Susan Steck |
University of South Carolina |
PLCO |
Mar 4, 2026 |
PLCO-2029 |
| Development of ML-Based Early Cancer Confirmation and Stage Classification Models for Ovarian and Colorectal Cancer Using PLCO Trial Data |
Dr. Mehdi Hasan Chowdhury |
Chittagong University of Engineering & Technology (CUET) |
PLCO |
Mar 4, 2026 |
PLCO-2026 |
| Effect of Stage and Grade on Colorectal Cancer Mortality |
Paul Pinsky |
National Institutes of Health |
PLCO |
Feb 26, 2026 |
PLCO-2028 |
| Early Risk Prediction of Ovarian Cancer Using Multimodal Clinical and Biomarker Data |
Vanshika Sharma |
Chandigarh University |
PLCO |
Feb 23, 2026 |
PLCO-2020 |
| A Risk-Stratified Decision Support Framework for Prostate Cancer Screening Using the PLCO Trial Dataset |
Priya Dubey |
Tokyo International University |
PLCO |
Feb 23, 2026 |
PLCO-2014 |
| Validation of CA-125 Kinetic Models for Early Ovarian Cancer Detection Using Machine Learning |
Fahad Kiani |
CrisPRO.ai |
PLCO |
Feb 23, 2026 |
PLCO-2010 |
| Plasma proteomics markers for risk prediction of incident lung cancer |
Charles Swanton |
Francis Crick Institute |
PLCO |
Feb 19, 2026 |
2025-0069 |
| DNA methylation and dietary sodium intake |
Jeong Yun (John) Yang |
Columbia University Irving Medical Center |
PLCO |
Feb 17, 2026 |
PLCO-2023 |
| Dietary Advanced Glycation End-Products (dAGE) and Prostate Cancer |
Susan Steck |
University of South Carolina |
PLCO |
Feb 13, 2026 |
PLCO-2021 |
| Computational Prediction of Gene Expression and Clinical Outcomes from Digital Pathology Images |
Mingyao Li |
University of Pennsylvania |
PLCO |
Feb 13, 2026 |
PLCOI-2022 |
